202 related articles for article (PubMed ID: 24429429)
1. Common use of the empirical combination of vancomycin and a β-lactam for staphylococcal bacteremia.
Cleveland KO; Mazumder SA; Gelfand MS
Clin Infect Dis; 2014 Apr; 58(7):1041-2. PubMed ID: 24429429
[No Abstract] [Full Text] [Related]
2. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
McConeghy KW; Bleasdale SC; Rodvold KA
Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant
Dilworth TJ; Casapao AM; Ibrahim OM; Jacobs DM; Bowers DR; Beyda ND; Mercier RC
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617094
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Truong J; Veillette JJ; Forland SC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133561
[TBL] [Abstract][Full Text] [Related]
5. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
[TBL] [Abstract][Full Text] [Related]
6. Focusing the Lens on the CAMERA Concepts: Early Combination β-Lactam and Vancomycin Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia.
Wilsey HA; Burgess DR; Burgess DS
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366709
[TBL] [Abstract][Full Text] [Related]
7. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
[TBL] [Abstract][Full Text] [Related]
8. Probability of eradication using vancomycin alone or in combination for methicillin-resistant Staphylococcus aureus bacteremia.
Chambers HF
Antimicrob Agents Chemother; 2014 Dec; 58(12):7617. PubMed ID: 25392536
[No Abstract] [Full Text] [Related]
9. Beta-lactam combination therapy for the treatment of Staphylococcus aureus and Enterococcus species bacteremia: A summary and appraisal of the evidence.
Bartash R; Nori P
Int J Infect Dis; 2017 Oct; 63():7-12. PubMed ID: 28789974
[TBL] [Abstract][Full Text] [Related]
10. Reply to "Probability of eradication using vancomycin alone or in combination for methicillin-resistant Staphylococcus aureus bacteremia".
Ibrahim OM; Dilworth TJ; Mercier RC
Antimicrob Agents Chemother; 2014 Dec; 58(12):7618-9. PubMed ID: 25392537
[No Abstract] [Full Text] [Related]
11. In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days.
Atalla E; Mylonakis E
Ann Intern Med; 2020 Jun; 172(12):JC67. PubMed ID: 32539506
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
Wong D; Wong T; Romney M; Leung V
BMC Infect Dis; 2016 May; 16():224. PubMed ID: 27215201
[TBL] [Abstract][Full Text] [Related]
13. Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis.
Kale-Pradhan PB; Giuliano C; Jongekrijg A; Rybak MJ
Pharmacotherapy; 2020 Jul; 40(7):648-658. PubMed ID: 32533859
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.
Wang C; Ye C; Liao L; Wang Z; Hu Y; Deng C; Liu L
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839217
[TBL] [Abstract][Full Text] [Related]
15. What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
García Aragonés L; Blanch Sancho JJ; Segura Luque JC; Mateos Rodriguez F; Martínez Alfaro E; Solís García Del Pozo J
Postgrad Med J; 2022 Jan; 98(1155):48-56. PubMed ID: 33563707
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
Wong D; Wong T; Romney M; Leung V
Ann Clin Microbiol Antimicrob; 2016 Apr; 15():27. PubMed ID: 27112143
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet?
Holland TL; Fowler VG
J Infect Dis; 2011 Aug; 204(3):329-31. PubMed ID: 21742827
[No Abstract] [Full Text] [Related]
18. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
Khatib R; Saeed S; Sharma M; Riederer K; Fakih MG; Johnson LB
Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):181-5. PubMed ID: 16505987
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
McDanel JS; Perencevich EN; Diekema DJ; Herwaldt LA; Smith TC; Chrischilles EA; Dawson JD; Jiang L; Goto M; Schweizer ML
Clin Infect Dis; 2015 Aug; 61(3):361-7. PubMed ID: 25900170
[TBL] [Abstract][Full Text] [Related]
20. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
Kim SH; Kim KH; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2008 Jan; 52(1):192-7. PubMed ID: 17984229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
